UBS AM’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84B | Buy |
|
|||||
|
2025
Q1 | $1.54B | Buy |
|
|||||
|
2024
Q4 | $1.13B | Buy |
|
|||||
|
2024
Q3 | $891M | Sell |
|
|||||
|
2024
Q2 | $764M | Buy |
|
|||||
|
2024
Q1 | $698M | Buy |
|
|||||
|
2023
Q4 | $765M | Buy |
|
|||||
|
2023
Q3 | $701M | Buy |
|
|||||
|
2023
Q2 | $739M | Hold |
|
|||||
|
2023
Q1 | $739M | Sell |
|
|||||
|
2022
Q4 | $805M | Sell |
|
|||||
|
2022
Q3 | $608M | Buy |
|
|||||
|
2022
Q2 | $570M | Sell |
|
|||||
|
2022
Q1 | $701M | Buy |
|
|||||
|
2021
Q4 | $672M | Buy |
|
|||||
|
2021
Q3 | $624M | Buy |
|
|||||
|
2021
Q2 | $598M | Sell |
|
|||||
|
2021
Q1 | $586M | Buy |
|
|||||
|
2020
Q4 | $524M | Buy |
|
|||||
|
2020
Q3 | $544M | Buy |
|
|||||
|
2020
Q2 | $635M | Buy |
|
|||||
|
2020
Q1 | $507M | Buy |
|
|||||
|
2019
Q4 | $430M | Buy |
|
|||||
|
2019
Q3 | $419M | Buy |
|
|||||
|
2019
Q2 | $438M | Sell |
|
|||||
|
2019
Q1 | $453M | Buy |
|
|||||
|
2018
Q4 | $382M | Buy |
|
|||||
|
2018
Q3 | $458M | Sell |
|
|||||
|
2018
Q2 | $427M | Buy |
|
|||||
|
2018
Q1 | $434M | Sell |
|
|||||
|
2017
Q4 | $426M | Sell |
|
|||||
|
2017
Q3 | $513M | Buy |
|
|||||
|
2017
Q2 | $432M | Sell |
|
|||||
|
2017
Q1 | $427M | Sell |
|
|||||
|
2016
Q4 | $494M | Sell |
|
|||||
|
2016
Q3 | $626M | Sell |
|
|||||
|
2016
Q2 | $734M | Sell |
|
|||||
|
2016
Q1 | $828M | Buy |
|
|||||
|
2015
Q4 | $875M | Sell |
|
|||||
|
2015
Q3 | $886M | Sell |
|
|||||
|
2015
Q2 | $1.13B | Sell |
|
|||||
|
2015
Q1 | $974M | Sell |
|
|||||
|
2014
Q4 | $976M | Buy |
|
|||||
|
2014
Q3 | $1.07B | Sell |
|
|||||
|
2014
Q2 | $901M | Sell |
|
|||||
|
2014
Q1 | $796M | Buy |
|
|||||
|
2013
Q4 | $769M | Sell |
|
|||||
|
2013
Q3 | $785M | Sell |
|
|||||
|
2013
Q2 | $745M | Buy |
|